These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22713225)

  • 21. Dramatic shrinkage of a giant prolactinoma in a male patient under medical management.
    Ippersiel W; Misson N; Donckier JE
    Acta Clin Belg; 2012; 67(2):140-1. PubMed ID: 22712173
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction.
    Corona G; Mannucci E; Jannini EA; Lotti F; Ricca V; Monami M; Boddi V; Bandini E; Balercia G; Forti G; Maggi M
    J Sex Med; 2009 May; 6(5):1457-66. PubMed ID: 19210705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluaton of therapy with cabergoline in men with macroprolactinoa.
    Andrysiak-Mamos E; Kaźmierczyk-Puchalska A; Zochowska E; Sowińska-Przepiera E; Sagan L; Kojder I; Syrenicz A
    Pomeranian J Life Sci; 2015; 61(3):263-9. PubMed ID: 27344867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary apoplexy during pregnancy.
    Chegour H; El Ansari N
    Pan Afr Med J; 2014; 17():211. PubMed ID: 25237408
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute shrinkage of a giant prolactinoma, masquerading as an erosive skull base tumour, with cabergoline.
    Dash S; Annamalai AK; Simpson HL; Sarkies N; Antoun NM; Mannion R
    QJM; 2013 Jan; 106(1):85. PubMed ID: 22075008
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment.
    Feneberg E; Gahr M; Baumgarten E; Connemann B; Merger S; Özpeynirci Y; Schönfeldt-Lecuona C
    J ECT; 2015 Jun; 31(2):e28-9. PubMed ID: 26000778
    [No Abstract]   [Full Text] [Related]  

  • 28. Cystic degeneration of macroprolactinoma on long-term cabergoline.
    Sharif DA; Nkonge FM; Chawda S; Benjamin J; Stojanović ND
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3593-4. PubMed ID: 20685886
    [No Abstract]   [Full Text] [Related]  

  • 29. Major depressive disorder induced by prolactinoma--a case report.
    Liao WT; Bai YM
    Gen Hosp Psychiatry; 2014; 36(1):125.e1-2. PubMed ID: 24182617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Bilbao I; Egaña N; García C; Olaizola I
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of cabergoline in the treatment of macroprolactinoma].
    Dupuy O; Le Marec E; Mayaudon H; Rilminger H; Bordier L; Bauduceau B
    Presse Med; 2003 Jan; 32(2):71-2. PubMed ID: 12653031
    [No Abstract]   [Full Text] [Related]  

  • 33. A 17-year-old female with secondary amenorrhea, galactorrhea, and headaches.
    Frohlich DM; Caldwell KJ; Rohrs H; Kelly MN
    J Pediatr Health Care; 2015; 29(2):205-11. PubMed ID: 25547318
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years.
    Shimon I; Hirsch D; Tsvetov G; Robenshtok E; Akirov A; Fraenkel M; Eizenberg Y; Herzberg D; Barzilay-Yoseph L; Livner A; Friedrich I; Manisterski Y; Ishay A; Yoel U; Masri H
    Endocrine; 2019 Sep; 65(3):656-661. PubMed ID: 31154607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of a hyperprolactinemia in a western lowland gorilla (Gorilla gorilla gorilla).
    Chatfield J; Zhang L; Ramey J; Bowsher T; Loskutoff N; O'Neill K
    J Zoo Wildl Med; 2006 Dec; 37(4):565-6. PubMed ID: 17315448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Giant prolactinoma causing cranio-cervical junction instability: a case report.
    Zaben MJ; Harrisson SE; Mathad NV
    Br J Neurosurg; 2011 Dec; 25(6):754-6. PubMed ID: 21344972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
    Iglesias P; Díez JJ
    Am J Med; 2011 Jun; 124(6):e3-4. PubMed ID: 21605718
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.
    Sala E; Bellaviti Buttoni P; Malchiodi E; Verrua E; Carosi G; Profka E; Rodari G; Filopanti M; Ferrante E; Spada A; Mantovani G
    J Endocrinol Invest; 2016 Dec; 39(12):1377-1382. PubMed ID: 27245604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.